AngioDynamics ANGO Acquisition, restructuring and other items, net
Acquisition, restructuring and other items, net at other companies
Other financials
Where this comes from
Reported directly by AngioDynamics in its filing.
Tagged under the XBRL concept ango:AcquisitionRestructuringAndOtherItemsNet.
The official record: AngioDynamics’s 10-Q, filed April 2, 2026, on SEC EDGAR. View the filing →
Ask your AI about AngioDynamics's acquisition, restructuring and other items, net.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is AngioDynamics's acquisition, restructuring and other items, net?
- AngioDynamics (ANGO) reported acquisition, restructuring and other items, net of $6.52M in Q4 2025.
- How has AngioDynamics's acquisition, restructuring and other items, net changed year-over-year?
- AngioDynamics's acquisition, restructuring and other items, net increased by 98.5% year-over-year, from $3.29M to $6.52M.
- What is the long-term trend for AngioDynamics's acquisition, restructuring and other items, net?
- Over 4 years (2021 to 2025), AngioDynamics's acquisition, restructuring and other items, net has grown at a -6.3% compound annual growth rate (CAGR), from $20.23M to $15.62M.
- What does acquisition, restructuring and other items, net mean?
- This metric aggregates non-recurring costs associated with integrating acquired entities, streamlining organizational structures, or exiting specific business lines. It captures expenses such as severance, facility closures, and professional fees related to corporate transformation initiatives. Tracking this helps investors distinguish between core operational performance and one-time charges that distort ongoing profitability.